Histopathological response (HR) after neoadjuvant chemotherapy (ChT) for high-risk soft tissue sarcomas (STS): A planned analysis of the ISG-STS-1001 trial.

Authors :: Pasquali, Sandro
Collini, Paola
Romagosa, Cleofe
Coindre, Jean Michel
Pizzamiglio, Sara
Verderio, Paolo
Barisella, Marta
Palmerini, Emanuela
Quagliuolo, Vittorio
Martin Broto, Javier
Lopez-Pousa, Antonio
Grignani, Giovanni
Blay, Jean-Yves
Lugowska, Iwona A.
Fontana, Valeria
Sbaraglia, Marta
Bague, Silvia
De Tos, Paolo
Casali, Paolo G
Gronchi, Alessandro
Source :: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p11511-11511, 1p
Publication Year :: 2023

Full Text Access

Tools